Urges Japan to honor its commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals by: (1) reducing regulatory barriers to the approval and adoption of new medical technologies; (2) establishing reasonable agency performance goals for premarket approvals and an appropriate, risk-based postmarket system consistent with globally accepted practices; (3) actively promoting pricing policies that encourage innovation; (4) implementing fair and open processes and rules that do not disproportionately harm United States medical technology products; and (5) providing opportunities for consultation with trading partners.
Read twice and referred to the Committee on Foreign Relations. (text of measure as introduced: CR S14364)
Introduced in House
Introduced in House
Referred to the House Committee on Ways and Means.
Referred to the Subcommittee on Trade.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line